Evoxac

Product NDC
0713-0915
Requested package NDC
0713-0915-75
11-digit product format
007130915
Labeler code
0713
Product ID
0713-0915_5fdb2294-e353-0887-e063-6394a90ad0a2
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
cevimeline hydrochloride
Dosage form
SOLUTION
Route
ORAL
Labeler
Cosette Pharmaceuticals, Inc.
Application
NDA221183
Marketing category
NDA
Marketing start
2026-10-15
Substance
CEVIMELINE HYDROCHLORIDE
Active strength
30 mg/5mL
Pharmacologic classes
Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N221183-001EVOXACCEVIMELINE HYDROCHLORIDE30MG/5MLSOLUTION / ORALRLD, RS2026-10-15

Orange Book patents#

Current patent rows page 1 of 1 · 1 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N221183-001125583472045-05-20U-4634Drug product2026-10-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N221183-001EVOXAC30MG/5MLSOLUTION / ORALRLD, RS2026-10-15d4dbc9d85df4…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-11-14 07:37:172026-10N221183-001125583472045-05-20U-4634Drug product2026-10-28d4dbc9d85df4…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Evoxac
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEVIMELINE HYDROCHLORIDE30 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
P81Q6V85NPInternal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
dac32a9b-05b8-42c2-9a29-d885a9279456Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5ee6cfc6-9666-4038-bf74-eee52d7e4a72Product name420250331

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EvoxacCEVIMELINE HYDROCHLORIDECosette Pharmaceuticals, Inc.dac32a9b-05b8-42c2-9a29-d885a92794562026-11-09Warnings, Adverse reactionsExact identifier
application applno (NDA): 221183
application number: NDA221183
ndc (package): 0713-0915-75
ndc (product): 0713-0915
ndc11 (package): 00713091575

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
309140cevimeline HCl 30 MG Oral CapsulePSNdac32a9b-05b8-42c2-9a29-d885a92794562
261361Evoxac 30 MG Oral CapsulePSNdac32a9b-05b8-42c2-9a29-d885a92794562
261361cevimeline hydrochloride 30 MG Oral Capsule [Evoxac]SBDdac32a9b-05b8-42c2-9a29-d885a92794562
309140cevimeline hydrochloride 30 MG Oral CapsuleSCDdac32a9b-05b8-42c2-9a29-d885a92794562
261361Evoxac 30 MG Oral CapsuleSYdac32a9b-05b8-42c2-9a29-d885a92794562

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0713-0915-7500713091575473 mL in 1 BOTTLE (0713-0915-75) 473 ml2026-10-15NoNoCurrent